RZLT
Rezolute, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.84
−2.78%Next report
Analyst consensus
- Next report date
- Sep 21, 2026
- EPS estimate
- -$0.15
- Revenue estimate
- —
Latest reported
- Last report date
- May 12, 2026
- EPS actual
- -$0.16
- EPS estimate
- -$0.14
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -8.2%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 12, 2026 | -$0.14 | -$0.16 | Miss -15.47% | — |
| Feb 12, 2026 | -$0.16 | -$0.22 | Miss -37.50% | — |
| Nov 6, 2025 | -$0.27 | -$0.18 | Beat 33.33% | — |
| Sep 17, 2025 | -$0.23 | -$0.26 | Miss -13.04% | — |
| Feb 12, 2025 | -$0.33 | -$0.22 | Beat 33.33% | — |
| Nov 7, 2024 | -$0.35 | -$0.22 | Beat 37.14% | — |
| Sep 19, 2024 | -$0.30 | -$0.44 | Miss -46.67% | $58.0K |
| May 15, 2024 | -$0.34 | -$0.34 | In line | — |
| Feb 13, 2024 | -$0.27 | -$0.27 | In line | — |
| Nov 13, 2023 | -$0.33 | -$0.28 | Beat 15.15% | — |
| Sep 14, 2023 | -$0.34 | -$0.25 | Beat 26.47% | — |
| May 11, 2023 | -$0.31 | -$0.30 | Beat 3.23% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026